中国癌症杂志 ›› 2016, Vol. 26 ›› Issue (8): 712-720.doi: 10.19401/j.cnki.1007-3639.2016.08.012

• 指南与共识 • 上一篇    

中国早期乳腺癌卵巢功能抑制临床应用专家共识(2016年版)

徐兵河1,邵志敏2,胡夕春3,江泽飞4   

  1. 1. 中国医学科学院肿瘤医院肿瘤内科,北京 100021 ;
    2. 复旦大学附属肿瘤医院乳腺外科,复旦大学上海医学院肿瘤学系,上海 200032 ;
    3. 复旦大学附属肿瘤医院肿瘤内科,复旦大学上海医学院肿瘤学系,上海 200032 ;
    4. 军事医学科学院附属医院乳腺肿瘤科,北京 100071
  • 出版日期:2016-08-30 发布日期:2016-10-19

XU Binghe1, SHAO Zhimin2, HU Xichun3, JIANG Zefei4   

  1. 1.Department of Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China; 2. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; 3. Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; 4. Department of Brest Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
  • Published:2016-08-30 Online:2016-10-19

关键词: 乳腺癌, 卵巢功能抑制, 内分泌治疗

Key words: Breast cancer, Ovarian function suppression, Endocrine therapy